251 related articles for article (PubMed ID: 12400005)
1. RACK1: a novel substrate for the Src protein-tyrosine kinase.
Chang BY; Harte RA; Cartwright CA
Oncogene; 2002 Oct; 21(50):7619-29. PubMed ID: 12400005
[TBL] [Abstract][Full Text] [Related]
2. RACK1 regulates Src-mediated Sam68 and p190RhoGAP signaling.
Miller LD; Lee KC; Mochly-Rosen D; Cartwright CA
Oncogene; 2004 Jul; 23(33):5682-6. PubMed ID: 15184885
[TBL] [Abstract][Full Text] [Related]
3. Receptor for activated C kinase 1 (RACK1) and Src regulate the tyrosine phosphorylation and function of the androgen receptor.
Kraus S; Gioeli D; Vomastek T; Gordon V; Weber MJ
Cancer Res; 2006 Nov; 66(22):11047-54. PubMed ID: 17108144
[TBL] [Abstract][Full Text] [Related]
4. Receptor association and tyrosine phosphorylation of S6 kinases.
Rebholz H; Panasyuk G; Fenton T; Nemazanyy I; Valovka T; Flajolet M; Ronnstrand L; Stephens L; West A; Gout IT
FEBS J; 2006 May; 273(9):2023-36. PubMed ID: 16640565
[TBL] [Abstract][Full Text] [Related]
5. The interaction of Src and RACK1 is enhanced by activation of protein kinase C and tyrosine phosphorylation of RACK1.
Chang BY; Chiang M; Cartwright CA
J Biol Chem; 2001 Jun; 276(23):20346-56. PubMed ID: 11279199
[TBL] [Abstract][Full Text] [Related]
6. The PDGF receptor phosphorylates Tyr 138 in the c-Src SH3 domain in vivo reducing peptide ligand binding.
Broome MA; Hunter T
Oncogene; 1997 Jan; 14(1):17-34. PubMed ID: 9010229
[TBL] [Abstract][Full Text] [Related]
7. Identification of Grb10 as a direct substrate for members of the Src tyrosine kinase family.
Langlais P; Dong LQ; Hu D; Liu F
Oncogene; 2000 Jun; 19(25):2895-903. PubMed ID: 10871840
[TBL] [Abstract][Full Text] [Related]
8. Replacing two conserved tyrosines of the EphB2 receptor with glutamic acid prevents binding of SH2 domains without abrogating kinase activity and biological responses.
Zisch AH; Pazzagli C; Freeman AL; Schneller M; Hadman M; Smith JW; Ruoslahti E; Pasquale EB
Oncogene; 2000 Jan; 19(2):177-87. PubMed ID: 10644995
[TBL] [Abstract][Full Text] [Related]
9. Src kinase activation by direct interaction with the integrin beta cytoplasmic domain.
Arias-Salgado EG; Lizano S; Sarkar S; Brugge JS; Ginsberg MH; Shattil SJ
Proc Natl Acad Sci U S A; 2003 Nov; 100(23):13298-302. PubMed ID: 14593208
[TBL] [Abstract][Full Text] [Related]
10. Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site.
Wallez Y; Cand F; Cruzalegui F; Wernstedt C; Souchelnytskyi S; Vilgrain I; Huber P
Oncogene; 2007 Feb; 26(7):1067-77. PubMed ID: 16909109
[TBL] [Abstract][Full Text] [Related]
11. Workshop cluster 1, a gammadelta T cell specific receptor is phosphorylated and down regulated by activation induced Src family kinase activity.
Pillai MR; Lefevre EA; Carr BV; Charleston B; O'Grady P
Mol Immunol; 2007 Mar; 44(7):1691-703. PubMed ID: 16997376
[TBL] [Abstract][Full Text] [Related]
12. Sequence specificity in the recognition of the epidermal growth factor receptor by the abl Src homology 2 domain.
Zhu G; Decker SJ; Maclean D; McNamara DJ; Singh J; Sawyer TK; Saltiel AR
Oncogene; 1994 May; 9(5):1379-85. PubMed ID: 8152798
[TBL] [Abstract][Full Text] [Related]
13. Mutational investigation of the specificity determining region of the Src SH2 domain.
Bradshaw JM; Mitaxov V; Waksman G
J Mol Biol; 2000 Jun; 299(2):521-35. PubMed ID: 10860756
[TBL] [Abstract][Full Text] [Related]
14. Nerve growth factor stimulates multisite tyrosine phosphorylation and activation of the atypical protein kinase C's via a src kinase pathway.
Wooten MW; Vandenplas ML; Seibenhener ML; Geetha T; Diaz-Meco MT
Mol Cell Biol; 2001 Dec; 21(24):8414-27. PubMed ID: 11713277
[TBL] [Abstract][Full Text] [Related]
15. v-Src induces Shc binding to tyrosine 63 in the cytoplasmic domain of the LDL receptor-related protein 1.
Barnes H; Ackermann EJ; van der Geer P
Oncogene; 2003 Jun; 22(23):3589-97. PubMed ID: 12789267
[TBL] [Abstract][Full Text] [Related]
16. The protein kinase C inhibitor Go6976 [12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole] potentiates agonist-induced mitogen-activated protein kinase activation through tyrosine phosphorylation of the epidermal growth factor receptor.
Shah BH; Olivares-Reyes JA; Catt KJ
Mol Pharmacol; 2005 Jan; 67(1):184-94. PubMed ID: 15465928
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine phosphorylation of caveolin-2 at residue 27: differences in the spatial and temporal behavior of phospho-Cav-2 (pY19 and pY27).
Wang XB; Lee H; Capozza F; Marmon S; Sotgia F; Brooks JW; Campos-Gonzalez R; Lisanti MP
Biochemistry; 2004 Nov; 43(43):13694-706. PubMed ID: 15504032
[TBL] [Abstract][Full Text] [Related]
18. RACK1 inhibits colonic cell growth by regulating Src activity at cell cycle checkpoints.
Mamidipudi V; Dhillon NK; Parman T; Miller LD; Lee KC; Cartwright CA
Oncogene; 2007 May; 26(20):2914-24. PubMed ID: 17072338
[TBL] [Abstract][Full Text] [Related]
19. Effects of prenyl pyrophosphates on the binding of PKCgamma with RACK1.
Chen YH; Wang HC; Lin CY; Chuang NN
J Exp Zool A Comp Exp Biol; 2003 Jan; 295(1):71-82. PubMed ID: 12506405
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of Src mutants at Tyr 527 in fibroblasts does not correlate with in vitro phosphorylation by CSK.
MacAuley A; Okada M; Nada S; Nakagawa H; Cooper JA
Oncogene; 1993 Jan; 8(1):117-24. PubMed ID: 7678701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
